Literature DB >> 10431834

C3-fullero-tris-methanodicarboxylic acid protects epithelial cells from radiation-induced anoikia by influencing cell adhesion ability.

E Straface1, B Natalini, D Monti, C Franceschi, G Schettini, M Bisaglia, C Fumelli, C Pincelli, R Pellicciari, W Malorni.   

Abstract

Anoikia is a type of apoptotic cell death that occurs in cells that are substrate-restricted in their growth. Buckminsterfullerenes represent a new class of chemical compounds with wide potential pharmacological antioxidant activity. In this report we provide the first demonstration that a water-soluble fullerene derivative, C3-fullero-tris-methanodicarboxylic acid, synthesized in our laboratories, is capable of inducing anoikia resistance in epithelial cells by a mechanism involving a 'trophic' effect on cell spreading-associated cytoskeletal components, i.e. on actin microfilaments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431834     DOI: 10.1016/s0014-5793(99)00812-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Molecular dynamics analysis of a buckyball-antibody complex.

Authors:  William H Noon; Yifei Kong; Jianpeng Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

Review 2.  The applications of buckminsterfullerene C60 and derivatives in orthopaedic research.

Authors:  Qihai Liu; Quanjun Cui; Xudong Joshua Li; Li Jin
Journal:  Connect Tissue Res       Date:  2014-01-24       Impact factor: 3.417

3.  Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.

Authors:  Jie Meng; Dong-liang Wang; Paul C Wang; Lee Jia; Chunying Chen; Xing-Jie Liang
Journal:  J Nanosci Nanotechnol       Date:  2010-12

4.  X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60).

Authors:  B C Braden; F A Goldbaum; B X Chen; A N Kirschner; S R Wilson; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

5.  Modulation of tumor necrosis factor-mediated cell death by fullerenes.

Authors:  Ljubica Harhaji; Aleksandra Isakovic; Ljubica Vucicevic; Kristina Janjetovic; Maja Misirkic; Zoran Markovic; Biljana Todorovic-Markovic; Nadezda Nikolic; Sanja Vranjes-Djuric; Zoran Nikolic; Vladimir Trajkovic
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

6.  Dissecting the Supramolecular Dispersion of Fullerenes by Proteins/Peptides: Amino Acid Ranking and Driving Forces for Binding to C60.

Authors:  Tainah Dorina Marforio; Alessandro Calza; Edoardo Jun Mattioli; Francesco Zerbetto; Matteo Calvaresi
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

7.  Fullerenemalonates inhibit amyloid beta aggregation, in vitro and in silico evaluation.

Authors:  Martínez-Herrera Melchor; Figueroa-Gerstenmaier Susana; García-Sierra Francisco; Beltrán Hiram I; Rivera-Fernández Norma; Lerma-Romero Jorge A; López-Camacho Perla Y; Basurto-Islas Gustavo
Journal:  RSC Adv       Date:  2018-11-27       Impact factor: 4.036

Review 8.  Medicinal applications of fullerenes.

Authors:  Rania Bakry; Rainer M Vallant; Muhammad Najam-ul-Haq; Matthias Rainer; Zoltan Szabo; Christian W Huck; Günther K Bonn
Journal:  Int J Nanomedicine       Date:  2007

9.  Adverse effects of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro.

Authors:  Monique P Gelderman; Olga Simakova; Jeffrey D Clogston; Anil K Patri; Sheena F Siddiqui; Alexander C Vostal; Jan Simak
Journal:  Int J Nanomedicine       Date:  2008

10.  Comparative computational study of interaction of C60-fullerene and tris-malonyl-C60-fullerene isomers with lipid bilayer: relation to their antioxidant effect.

Authors:  Marine E Bozdaganyan; Philipp S Orekhov; Alexey K Shaytan; Konstantin V Shaitan
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.